SARS-CoV-2 Spike Glycoprotein (D614G Mutation) from ABBEXA LTD
Search, find, compare suppliers for SARS-CoV-2 Spike Glycoprotein (D614G Mutation) products.
| Edit | |
|---|---|
| Product Name | SARS-CoV-2 Spike Glycoprotein (D614G Mutation) |
| Description | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Glycoprotein, D614G Variant is a full-length recombinant protein expressed in HEK293 cells. It contains the foldon trimerization motif, mutated Furin recognition site and 2 stabilising mutations (K986P and V987P), based on/modified from Amanat et al, 2020. The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action. 16-1213 AA. C-terminal 8 His tag. Purity > 90% (SDS-PAGE). Calculated MW: 137 kDa Observed MW (SDS-PAGE): 190 kDa |
| Size | 100 µg |
| Concentration | n/a |
| Applications | WB |
| Other Names | Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, COVID-19, 2019-nCoV, 2019 novel coronavirus, COVID19, S1 protein, 2019-nCoV S1 protein, coronavirus S1 Protein, cov S1 Protein, Severe Acute Respiratory Syndrome Coronavirus 2 protein, Protein Severe Acute Respiratory Syndrome Coronavirus 2, Human Severe Acute Respiratory Syndrome Coronavirus 2 Protein, Human Severe Acute Respiratory Syndrome Coronavirus 2, Human protein Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2 protein, Protein SARS-CoV-2, Human SARS-CoV-2 Protein, Human SARS-CoV-2, Human protein SARS-CoV-2, COVID-19 protein, Protein COVID-19, Human COVID-19 Protein, Human COVID-19, Human protein COVID-19, 2019-nCoV protein, Protein 2019-nCoV, Human 2019-nCoV Protein, Human 2019-nCoV, Human protein 2019-nCoV, 2019 novel coronavirus protein, Protein 2019 novel coronavirus, Human 2019 novel coronavirus Protein, Human 2019 novel coronavirus, Human protein 2019 novel coronavirus, COVID19 protein, Protein COVID19, Human COVID19 Protein, Human COVID19, Human protein COVID19, S1 protein protein, Protein S1 protein, Human S1 protein Protein, Human S1 protein, Human protein S1 protein, 2019-nCoV S1 protein protein, Protein 2019-nCoV S1 protein, Human 2019-nCoV S1 protein Protein, Human 2019-nCoV S1 protein, Human protein 2019-nCoV S1 protein, coronavirus S1 Protein protein, Protein coronavirus S1 Protein, Human coronavirus S1 Protein Protein, Human coronavirus S1 Protein, Human protein coronavirus S1 Protein, cov S1 Protein protein, Protein cov S1 Protein, Human cov S1 Protein Protein, Human cov S1 Protein, Human protein cov S1 Protein |
| Gene, Accession, CAS # | UniProt: P0DTC2 |
| Catalog # | abx169319 |
| Price | please inquire |
| Order / More Info | SARS-CoV-2 Spike Glycoprotein (D614G Mutation) from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Products